Clearstead Advisors’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Sell
143,203
-20,786
-13% -$489K 0.03% 281
2026
Q1
$2.45M Buy
163,989
+222
+0.1% +$3.79K 0.02% 323
2025
Q4
$2.38M Buy
163,767
+1,000
+0.6% +$17.4K 0.03% 302
2025
Q3
$2.92M Sell
162,767
-800
-0.5% -$11.7K 0.04% 261
2025
Q2
$2.79M Buy
163,567
+7,253
+5% +$72.6K 0.04% 266
2025
Q1
$1.13M Sell
156,314
-25,000
-14% -$285K 0.02% 383
2024
Q4
$2.55M Sell
181,314
-32,462
-15% -$480K 0.04% 258
2024
Q3
$2.54M Buy
213,776
+67,724
+46% +$702K 0.04% 263
2024
Q2
$1.36M Buy
+146,052
New +$746K 0.02% 339

Other funds holding CORZ

Clearstead Advisors's CORZ Position: Q2 2026 in Review

Clearstead Advisors reduced its Core Scientific (CORZ) stake by 13% in Q2 2026, selling an estimated $489K and leaving 143,203 shares worth $3.66M. The position accounts for 0.03% of the portfolio, ranked #281.

Clearstead Advisors first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Clearstead Advisors held 143,203 shares of Core Scientific worth $3.66M as of Q2 2026.
  • Clearstead Advisors sold 20,786 Core Scientific shares in Q2 2026, an estimated $489K.
  • Core Scientific made up 0.03% of Clearstead Advisors's portfolio in Q2 2026, its #281 holding.
  • Clearstead Advisors first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.